XV5-18174-14061
4 vaccinations
5 coded responses
52 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 841 / UT
- Registered
- 2021-04-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Dose 1 — Pfizer-BioNTech
-
2021-04-10
Registered in v-safe
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-23
- 2021-04-30
-
2021-05-07
Dose 2 — Pfizer-BioNTech
- 2021-05-07
- 2021-05-08
- 2021-05-09
- 2021-05-10
- 2021-05-11
- 2021-05-12
- 2021-05-13
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-06-11
- 2021-06-18
- 2021-08-06
- 2021-11-05
-
2021-11-19
Dose 3 — Pfizer-BioNTech
- 2021-11-19
- 2021-11-20
- 2021-11-21
- 2021-11-22
- 2021-11-23
- 2021-11-24
- 2021-11-25
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2021-12-17
- 2021-12-24
- 2021-12-31
- 2022-02-18
- 2022-05-20
-
2022-09-16
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-18
- 2022-09-19
- 2022-09-20
-
2022-09-21
Survey response — days 1–6 daily, dose 4MedDRA: Chest discomfort, Exposure to SARS-CoV-2, Quarantine — Feeling: Fair · HeadacheMedDRA releases: 2024-11 · check-in answers available
-
2022-09-22
Survey response — days 1–6 daily, dose 4MedDRA: Chest discomfort, Respiratory tract congestion — Feeling: FairMedDRA releases: 2024-11 · check-in answers available
-
2022-09-23
Survey response — 7 day, dose 4MedDRA: Chest discomfort, Pharyngeal contusion, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
-
2022-09-30
Survey response — 14 day, dose 4MedDRA: Exposure to SARS-CoV-2, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
- 2022-10-07
- 2022-10-14
- 2022-10-21
-
2022-10-28
Survey response — 42 day, dose 4MedDRA: Hypersensitivity, Pre-existing disease — Feeling: FairMedDRA releases: 2024-11 · check-in answers available
- 2022-12-16
- 2023-03-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Pfizer-BioNTech | |
| 2 | 2021-05-07 | Pfizer-BioNTech | |
| 3 | 2021-11-19 | Pfizer-BioNTech | No |
| 4 | 2022-09-16 | Pfizer-BioNTech | Flu |
Free text
Release 12
Systemic reaction (other): Chest a bit tight. Roommate tested positive 2 days ago. Isolating separately
Systemic reaction (other): Weight on/in chest, throat congestion but not sore throat. Roommate tested positive Monday 09/19
Systemic reaction (other): Chest tightness/pressure, bruised throat, building congestion. Roommate tested positive 09/19, awaiting own PCR results
Symptoms: Exposed to covid 2 days after bivalent booster. Tested positive for covid Sept 23. Atypical symptoms.
Symptoms: Allergies flaring up as I foster kittens
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Chest discomfort | · | · | ✓ |
| SRO | Exposure to SARS-CoV-2 | · | · | ✓ |
| SRO | Pharyngeal contusion | · | · | ✓ |
| SRO | Quarantine | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release